Journal of the National Cancer Institute Advance Access published online on August 28, 2007
JNCI Journal of the National Cancer Institute, doi:10.1093/jnci/djm129
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2007. Published by Oxford University Press.
EDITORIALS |
Is a Screening Interval of Every 4 Years for Prostate Cancer Acceptable?
Correspondence to: E. David Crawford, MD, Division of Urologic Oncology, University of Colorado Health Sciences Center, Mail Stop # F 710, PO Box # 6510, Aurora, CO 80045 (e-mail: david.crawford@uchsc.edu).
| The first 10% of the full text of this article appears below. |
In this issue of the Journal, Roobol et al. (1) report an analysis of two different screening intervals in the large European Randomized study of Screening for Prostate Cancer (ERSPC) to defend a screening interval of every 4 years. In contrast to the yearly screening for prostate cancer in the United States, most centers in the ERSPC trial chose to screen men every 4 years. Critics of the 4-year screening interval have voiced concerns that clinically significant cancers could be missed by such an extended interval. The
Correspondence about this Article
Related Articles in JNCI
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2008 100: 222.
J Natl Cancer Inst 2007 99: 1296-1303.
J Natl Cancer Inst 2007 99: 1277.
J Natl Cancer Inst 2007 99: 1277.
J Natl Cancer Inst 2007 99: 1277.
J Natl Cancer Inst 2007 99: 1277.
This article has been cited by other articles:
![]() |
Is Less-Intensive Prostate Cancer Screening Appropriate? Journal Watch Oncology and Hematology, October 2, 2007; 2007(1002): 2 - 2. [Full Text] |
||||
